Team members for the Biocina
Adam Gickling is Executive Vice President and Chief Operating Officer at the Bridgewest Group. Adam oversees all aspects of corporate finance and operational strategy. Additionally, he is an active contributor to the operational success of the Bridgewest Group’s portfolio of companies. Through his business acumen and servant leadership style, he fuels a strong multi-talented organizational […]
Mark W. Womack is BioCina’s Chief Executive Officer, and in his first 9 months at the helm he led BioCina to a 500% YOY increase in sales and a 250% YOY increase in revenue. Following BioCina’s merger with NovaCina in January 2025 (with the combined company retaining the BioCina name), Mr. Womack created a powerful
Jason Arcediano brings an impressive 30 years of experience in the biologics industry to BioCina.
Brett Alderson is a veteran leader in the pharmaceutical industry, predominantly working with the manufacturing of sterile injectables. Brett is a determined and thoughtful leader adept at driving business success and leading through transformative change. He is a champion for clients, instilling a client-centric culture, with transparency and helpfulness. He enjoys mentoring and nurturing a
Michael Tsaconas is BioCina’s Vice President and General Manager. Michael is a seasoned executive with more than 20 years experience in pharmaceutical manufacturing of liquids, creams, solid oral dose forms and large molecule drug substance at companies including FH Faulding, Mayne Pharma, Hospira and most recently Pfizer. Michael has worked in the areas of Quality
Jan Bekker is BioCina’s Vice President Business Development and Commercial Operations. Jan is a biopharmaceutical industry professional with over 20 years academic and industry experience with previous roles at Pfizer, Hospira, Centre for Marine Bioproducts Development, Stellenbosch University, and the Queensland University of Technology. Jan’s significant industry experience and technical knowledge allows him to tailor
Tommy Broudy is a passionate biotech executive with a 20+ year track record building and growing companies in life science tools, diagnostics and therapeutics. As Operating Partner, he works with portfolio companies to create value, set strategy, build teams, establish partnerships, achieve milestones, and generate successful outcomes for all stakeholders. Tommy was part of the
Rick Hancock was appointed to the Board of Directors as Executive Chairman in January 2022. Rick has worked in the Biotechnology Industry for over 35 years, including 20 years with various CDMOs in operational and executive roles. Most recently, he served as Interim President and CEO at Avid Bioservices and prior to that, as President
Mike Cicio has worked in the Biotechnology Industry for over 30 years as a hands-on executive with experience with both world class innovators and CDMOs. Experienced in general management of clinical and commercial biotechnology business with a focus on operations. Mike has extensive experience in a variety of biotechnology platforms. Mike received a BS in
